Korean J Gastroenterol.  2019 Jan;73(1):1-2. 10.4166/kjg.2019.73.1.1.

Radiation Therapy for the Treatment of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

• Gong EJ

• KMID: 2432427
• DOI: http://doi.org/10.4166/kjg.2019.73.1.1

Abstract

No abstract available.

MeSH Terms

Lymphoma, B-Cell, Marginal Zone*

Reference

1. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991; 338:1175–1176.

2. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012; 61:507–513.

3. Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010; 8:105–110.

4. Gong EJ, Ahn JY, Jung HY, et al. Helicobacter pylori eradication therapy Is effective as the initial treatment for patients with H. pylori-negative and disseminated gastric mucosa-associated lymphoid tissue lymphoma. Gut Liver. 2016; 10:706–713.

5. Zullo A, Hassan C, Ridola L, et al. Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review. J Clin Gastroenterol. 2013; 47:824–827.

6. Zucca E, Copie-Bergman C, Ricardi U, et al. Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24:Suppl 6. vi144–vi148.

7. Ruskoné-Fourmestraux A, Fischbach W, Aleman BM, et al. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 2011; 60:747–758.

8. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) B-Cell Lymphomas Version 2.2018. [Internet]. Plymouth Meeting: National Comprehensive Cancer Network;2018. 02. 26. cited 2018 Dec 31. Available from: http://www.nccn.org/professionals/physician_gls/pdf.

9. Tsang RW, Gospodarowicz MK. Radiation therapy for localized low-grade non-Hodgkin's lymphomas. Hematol Oncol. 2005; 23:10–17.

10. Abe S, Oda I, Inaba K, et al. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy. Jpn J Clin Oncol. 2013; 43:917–922.

11. Park BS, Lee SH. Clinical efficacy of radiotherapy in Helicobacter pylori negative or unresponsive to eradication therapy primary gastric mucosa-associated lymphoid tissue lymphoma. Korean J Gastroenterol. 2019; 73:19–25.

12. Hong SS, Jung HY, Choi KD, et al. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter. 2006; 11:569–573.

13. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut. 2007; 56:1685–1687.